Centessa Pharmaceuticals Limited

CNTA53

$17.500.00%$0.00

CNTA53

$17.50

0.00%$0.00

Performance History

Key Stats
Open	$17.50
Prev. Close	$18.08
EPS	-1.55
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	16.96	18.02
52 Week Range	5.58	18.49

Ratios







EPS	-1.55

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Centessa Pharmaceuticals Limited (CNTA)

Centessa Pharmaceuticals Limited (CNTA) is a biopharmaceutical company that focuses on developing and commercializing transformative medicines. With a mission to address the urgent needs of the most challenging diseases, Centessa is dedicated to making a positive impact on patients' lives. The company utilizes a unique and innovative model that brings together world-class scientists and drug development experts from across its portfolio of companies. By leveraging their collective expertise, Centessa aims to accelerate the discovery and development of novel therapies.

As of the latest stock price history, Centessa Pharmaceuticals Limited (CNTA) has shown significant growth and resilience in the market. The company's stock has consistently performed well, reflecting the market's confidence in its potential. It is an exciting time for Centessa, as it continues to achieve key milestones in its drug development pipeline.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Saurabh Saha M.D., Ph.D.
Headquarters: Altrincham
Employees: 64
Exchange: NASDAQ

add Centessa Pharmaceuticals Limited to watchlist

Keep an eye on Centessa Pharmaceuticals Limited

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Centessa Pharmaceuticals Limited's (CNTA) price per share?

The current price per share for Centessa Pharmaceuticals Limited (CNTA) is $17.5. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Centessa Pharmaceuticals Limited (CNTA)?

For Centessa Pharmaceuticals Limited (CNTA), the 52-week high is $18.5, which is 5.7% from the current price. The 52-week low is $5.58, the current price is 213.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Centessa Pharmaceuticals Limited (CNTA) a growth stock?

Centessa Pharmaceuticals Limited (CNTA) has shown an average price growth of -3.55% over the past three years. It has received a score of 90 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Centessa Pharmaceuticals Limited as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Centessa Pharmaceuticals Limited (CNTA) stock price performance year to date (YTD)?

As of the latest data, Centessa Pharmaceuticals Limited (CNTA) has a year-to-date price change of 117.93%. Over the past month, the stock has experienced a price change of 5.04%. Over the last three months, the change has been 38.89%. Over the past six months, the figure is 93.58%.

help

Is Centessa Pharmaceuticals Limited (CNTA) a profitable company?

Centessa Pharmaceuticals Limited (CNTA) has a net income of -$151.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.18% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.36K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.88M, although specific revenue growth data is currently not available. The gross profit is $6.07M. Operating income is noted at -$171.95M. Furthermore, the EBITDA is -$155.1M.

help

What is the market capitalization of Centessa Pharmaceuticals Limited (CNTA)?

Centessa Pharmaceuticals Limited (CNTA) has a market capitalization of $2.25B. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.

News

CENTESSA PHARMACEUTICALS

ORX750

NARCOLEPSY

IDIOPATHIC HYPERSOMNIA

SERPINPC

Nov 12, 2024

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

CENTESSA PHARMACEUTICALS

PUBLIC OFFERING

ADSS

CLINICAL-STAGE PHARMACEUTICAL PROGRAMS

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

CENTESSA PHARMACEUTICALS

ORX750

OREXIN RECEPTOR 2 AGONIST

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

DIRECTORS AND OFFICERS

Jun 10, 2024

Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer

May 28, 2024

Down -10.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Centessa Pharmaceuticals (CNTA)

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS

May 21, 2024

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences